Fanconi anemia: A disorder defective in the DNA damage response

Hiroyuki Kitao, Minoru Takata

Research output: Contribution to journalReview article

53 Citations (Scopus)

Abstract

Fanconi anemia (FA) is a cancer predisposition disorder characterized by progressive bone marrow failure, congenital developmental defects, chromosomal abnormalities, and cellular hypersensitivity to DNA interstrand crosslink (ICL) agents. So far mutations in 14 FANC genes were identified in FA or FA-like patients. These gene products constitute a common ubiquitin-phosphorylation network called the "FA pathway" and cooperate with other proteins involved in DNA repair and cell cycle control to repair ICL lesions and to maintain genome stability. In this review, we summarize recent exciting discoveries that have expanded our view of the molecular mechanisms operating in DNA repair and DNA damage signaling.

Original languageEnglish
Pages (from-to)417-424
Number of pages8
JournalInternational journal of hematology
Volume93
Issue number4
DOIs
Publication statusPublished - Apr 1 2011

Fingerprint

Fanconi Anemia
DNA Damage
DNA Repair
Genomic Instability
Ubiquitin
Cell Cycle Checkpoints
Chromosome Aberrations
Genes
Hypersensitivity
Bone Marrow
Phosphorylation
Mutation
DNA
Neoplasms
Proteins

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Fanconi anemia : A disorder defective in the DNA damage response. / Kitao, Hiroyuki; Takata, Minoru.

In: International journal of hematology, Vol. 93, No. 4, 01.04.2011, p. 417-424.

Research output: Contribution to journalReview article

@article{fbfd04e78ec44c488b1e3318af011cdb,
title = "Fanconi anemia: A disorder defective in the DNA damage response",
abstract = "Fanconi anemia (FA) is a cancer predisposition disorder characterized by progressive bone marrow failure, congenital developmental defects, chromosomal abnormalities, and cellular hypersensitivity to DNA interstrand crosslink (ICL) agents. So far mutations in 14 FANC genes were identified in FA or FA-like patients. These gene products constitute a common ubiquitin-phosphorylation network called the {"}FA pathway{"} and cooperate with other proteins involved in DNA repair and cell cycle control to repair ICL lesions and to maintain genome stability. In this review, we summarize recent exciting discoveries that have expanded our view of the molecular mechanisms operating in DNA repair and DNA damage signaling.",
author = "Hiroyuki Kitao and Minoru Takata",
year = "2011",
month = "4",
day = "1",
doi = "10.1007/s12185-011-0777-z",
language = "English",
volume = "93",
pages = "417--424",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Fanconi anemia

T2 - A disorder defective in the DNA damage response

AU - Kitao, Hiroyuki

AU - Takata, Minoru

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Fanconi anemia (FA) is a cancer predisposition disorder characterized by progressive bone marrow failure, congenital developmental defects, chromosomal abnormalities, and cellular hypersensitivity to DNA interstrand crosslink (ICL) agents. So far mutations in 14 FANC genes were identified in FA or FA-like patients. These gene products constitute a common ubiquitin-phosphorylation network called the "FA pathway" and cooperate with other proteins involved in DNA repair and cell cycle control to repair ICL lesions and to maintain genome stability. In this review, we summarize recent exciting discoveries that have expanded our view of the molecular mechanisms operating in DNA repair and DNA damage signaling.

AB - Fanconi anemia (FA) is a cancer predisposition disorder characterized by progressive bone marrow failure, congenital developmental defects, chromosomal abnormalities, and cellular hypersensitivity to DNA interstrand crosslink (ICL) agents. So far mutations in 14 FANC genes were identified in FA or FA-like patients. These gene products constitute a common ubiquitin-phosphorylation network called the "FA pathway" and cooperate with other proteins involved in DNA repair and cell cycle control to repair ICL lesions and to maintain genome stability. In this review, we summarize recent exciting discoveries that have expanded our view of the molecular mechanisms operating in DNA repair and DNA damage signaling.

UR - http://www.scopus.com/inward/record.url?scp=79955942240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955942240&partnerID=8YFLogxK

U2 - 10.1007/s12185-011-0777-z

DO - 10.1007/s12185-011-0777-z

M3 - Review article

C2 - 21331524

AN - SCOPUS:79955942240

VL - 93

SP - 417

EP - 424

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 4

ER -